Authors: van Oosterhout, YVJM van Emst, JL Bakker, HH Preijers, FWMB Schattenberg, AVMB Ruiter, DJ Evers, S Koopman, JP de Witte, T

Citation: Yvjm. Van Oosterhout et al., Production of anti-CD3 and anti-CD7 ricin A-immunotoxins for a clinical pilot study, INT J PHARM, 221(1-2), 2001, pp. 175-186

Authors: Van Horssen, PJ Preijers, FWMB Van Oosterhout, YVJM Eling, WMC De Witte, T

Citation: Pj. Van Horssen et al., Relationship of the CD22 immunotoxin dose and the tumour establishment in a SCID mice model, LEUK LYMPH, 39(5-6), 2000, pp. 591-599

Authors: van Oosterhout, YVJM van Emst, L Schattenberg, AVMB Tax, WJM Ruiter, DJ Spits, H Nagengast, FM Masereeuw, R Evers, S de Witte, T Preijers, FWMB

Citation: Yvjm. Van Oosterhout et al., A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease, BLOOD, 95(12), 2000, pp. 3693-3701

Authors: van Horssen, PJ van Oosterhout, YVJM Evers, S Backus, HHJ van Oijen, MGCT Bongaerts, R de Witte, T Preijers, FWMB

Citation: Pj. Van Horssen et al., Influence of cytotoxicity enhancers in combination with human serum on theactivity of CD22-recombinant ricin A against B cell lines, chronic and acute lymphocytic leukemia cells, LEUKEMIA, 13(2), 1999, pp. 241-249

Authors: Preijers, FWMB van Hennik, PB Schattenberg, A Ruijs, P Ploemacher, RE de Witte, T

Citation: Fwmb. Preijers et al., Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells, BONE MAR TR, 23(10), 1999, pp. 1061-1070

Authors: Soetekouw, PMMB de Vries, M Preijers, FWMB van Crevel, R Bleijenberg, G van der Meer, JWM

Citation: Pmmb. Soetekouw et al., Persistent symptoms in former UNTAC soldiers are not associated with shifted cytokine balance, EUR J CL IN, 29(11), 1999, pp. 960-963